Glibenclamide | Interleukin Related interleukin-related.com

Product Name :
Glibenclamide

Search keywords :
Glibenclamide

drugId :
null

Target Vo:
Sulfonylurea receptor 1

Target Vo Short Name :
SUR1

Moa_Name:
Sulfonylurea receptor 1 inhibitors

First Approval Country :
Japan

First Approval Date Filter:
1971

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Ammtek

Active Indication_Name:
Diabetes Mellitus

In Active Indication_Name:
Brain Contusion

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
His Tag (C-terminal) Antibody
N Cadherin Antibody
CD46 Antibody: CD46 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to CD46. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts